Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-12-18

EMA Authorised: Orgalutran (ganirelix) — Organon N.V.

View source ↗

Summary

The EMA authorised Orgalutran (ganirelix) from Organon N.V. for use in assisted reproductive techniques, including ovulation induction, to treat female infertil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orgalutran (ganirelix)

Snippet

Status: Authorised. Therapeutic area: Reproductive Techniques, Assisted;Ovulation Induction;Infertility, Female. MAH: Organon N.V.. Decision date: 18/12/2025